A carregar...
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
PURPOSE OF REVIEW: CMV DNA polymerase inhibitors such as ganciclovir and foscarnet have dramatically reduced the burden of CMV infection in the HCT recipient. However, their use is often limited by toxicities and resistance. Agents with novel mechanisms and favorable toxicity profiles are critically...
Na minha lista:
| Publicado no: | Curr Hematol Malig Rep |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223398/ https://ncbi.nlm.nih.gov/pubmed/31981100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-020-00557-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|